Integrated research field related to biometals and in symbiosis with genomics and proteomics. In metallomics, metalloproteins, metalloenzymes and other metal- containing biomolecules are defined as ‘‘metallomes’’, in a similar manner to genomes in genomics as well as proteomes in proteomics. In the study of metallomics, elucidation of the physiological roles and functions of biomolecules binding with metallic ions in the biological systems should be the most important research target. Then, metallomics may be called, in another words, ‘‘metal-assisted function biochemistry’’.

The term "metallomics" was found in the following pages:

15th Rio Symposium on Atomic Spectrometry | EVISA's Agenda of Events
Elemental speciation is going commercial | EVISA's News
Thiomersal in influenza vaccine: more than just an adjuvant | EVISA's News
Special issue on "Advances in speciation techniques and methodology" available | EVISA's News
Species transformation during speciation analysis | EVISA's News
EVISA's activities during the year 2011 | EVISA's News
Analytik Jena AG Expands its Product Range | EVISA's News
Impressions from the 6th Metallomics Symposium | EVISA's News
Mercury-binding proteins in tuna and salmon | EVISA's News
Directory of scientists: Robyn Hannigan
Books and Special Issues on Elemental Speciation (published between 2006 and 2010) | EVISA's News
Determination of methylmercury complexes with low molecular mass thiols | EVISA's News
New isotope ratio mass spectrometry system delivers high-precision analysis for a range of applications | EVISA's News
Metallomics-2015: Vth International Symposium on Metallomics | EVISA's Agenda of Events
Chemical speciation analysis for life science | EVISA's News
METALLOMICS 2013 | EVISA's Agenda of Events
Efficiency of some papillomavirus vaccines is reduced in the presence of thimerosal | EVISA's News
METALLOMICS 2011: 3rd International Symposium on Metallomics | EVISA's Agenda of Events
LC-ICP-MS: The most often used hyphenated system for speciation analysis | EVISA's News
New Studies Question Safety of MRI Contrast Agents | EVISA's News